Organization | Solvay

Solvay Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4

Founded: Brussels Belgium (1863)

Status: Acquired by Abbott (2009)

Organization Overview

First Clinical Trial

2000

NCT00266721

First Marketed Drug

1962

dydrogesterone (gynorest)

First NDA Approval

1962

dydrogesterone (gynorest)

Last Known Activity

2010

Timeline

NOW

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Solace Pharmaceuticals | SOLVAY | Solvay Biologicals | Solvay Pharmaceuticals

Active Ingredients

Marketed Drugs (24)

benzthiazide (fovane) (1965)

butabarbital (neonal) (1974)

dexamethasone (1975)

dienestrol (1975)

dydrogesterone (gynorest) (1962 NDA)

estrogens, esterified (menrium component estrogens, esterified) (1977)

fluvoxamine (luvox) (1994 NDA)

hydralazine (apresoline) (1982)

hydrochlorothiazide (esidrix) (1977)

levonordefrin (Neo-Cobefrine) (1976)

lithium (lithonate) (1970)

medroxyprogesterone (provera) (1978)

mepivacaine (carbocaine) (1975)

meprobamate (equanil) (1967)

methocarbamol (robaxin) (1976)

pancrelipase (creon) (2009 NDA)

phentermine (wyamine) (1976)

prednisone (meticorten) (1974)

pyridostigmine bromide (mestinon) (1990)

rauwolfia alkaloids (1972)

reserpine (serpasil) (1972)

sulfasalazine (azulfidine) (1974)

sulfisoxazole (gantrisin) (1972)

urea (1975)

Drugs in Phase 4 Trials (19)

Key: Solvay (13) Acquired (6)

betahistine mesilate (1 trial)

calcium (1 trial)

dutasteride (avodart) (1 trial)

dydrogesterone (gynorest) (3 trials)

estradiol (progynon depot) (5 trials)

fluvoxamine (luvox) (2 trials)

icosapent ethyl (vascepa) (3 trials)

lactulose (cephulac) (2 trials)

levodopa (larodopa) (3 trials)

neomycin (2 trials)

nystatin (mycostatin) (2 trials)

pancrelipase (creon) (9 trials)

plantago ovata (1 trial)

polymyxin b sulfate (poly-rx) (2 trials)

progesterone (progestasert) (1 trial)

testosterone (delatestryl) (22 trials)

tibolone (xyvion) (1 trial)

virosomal influenza vaccine (2 trials)

vitamin d3 (2 trials)

Drugs in Phase 3 Trials (27)

Key: Solvay (23) Acquired (4)

acetaminophen (tylenol) (1 trial)

aripiprazole (abilify) (1 trial)

atorvastatin (lipitor) (1 trial)

bifeprunoxum (13 trials)

dronabinol (marinol) (6 trials)

ezetimibe (zetia) (1 trial)

fenofibrate (fenoglide) (17 trials)

gemfibrozil (lopid) (1 trial)

Goflikicept (4 trials)

ibipinabant (2 trials)

inactivated influenza vaccine (6 trials)

miconazole (monistat) (1 trial)

normocoxib (normoxocin) (1 trial)

olanzapine (zyprexa) (1 trial)

ondansetron (zofran) (1 trial)

palonosetron (aloxi) (1 trial)

pardoprunox (6 trials)

placental tissue extract (1 trial)

pramipexole (mirapex) (1 trial)

pravastatin (pravachol) (1 trial)

quetiapine (seroquel) (2 trials)

risperidone (risperdal) (2 trials)

simvastatin (zocor) (5 trials)

sitagliptin (januvia) (9 trials)

tedisamil sesquifumarate (3 trials)

urea (1 trial)

ziprasidone (geodon) (1 trial)

Drugs in Phase 2 Trials (11)

Key: Solvay (8) Acquired (3)

celecoxib (celebrex) (1 trial)

cetrorelix (cetrotide) (1 trial)

cxa-10 (1 trial)

daglutril (2 trials)

derenofylline (3 trials)

diclofenac (voltaren) (1 trial)

estrogens, esterified (menrium component estrogens, esterified) (4 trials)

methyltestosterone (testred) (4 trials)

microbial lipase slv339 (1 trial)

slc022 (1 trial)

ubiquinone (1 trial)

Drugs in Phase 1 Trials (12)

Key: Solvay (7) Acquired (5)

13c-pyruvate (1 trial)

alpha-lipoic acid (1 trial)

interferon gamma-1b (actimmune) (1 trial)

nitazoxanide (Alinia) (1 trial)

pioglitazone (actos) (1 trial)

pregabalin (lyrica) (1 trial)

Drugs in Other Trials (8)

Key: Solvay (4) Acquired (4)

2-butanol (1 trial)

anastrozole (arimidex) (1 trial)

eprosartan (teveten) (1 trial)

goserelin (zoladex) (1 trial)

hydrochlorothiazide (esidrix) (1 trial)

indocyanine green (ic-green) (1 trial)

naltrexone (revia) (1 trial)

sodium chloride (1 trial)

Indications

Approved Indications

Dysmenorrhea

Endometriosis

Obsessive-Compulsive Disorder

Premenstrual Syndrome

Experimental Indications (Clinical Trials, Phases 1-4)

Alzheimer Disease (Phase 3)

Amenorrhea (Phase 4)

Apnea (Phase 2)

Atherosclerosis (Phase 4)

Atrial Fibrillation (Phase 3)

Atrial Flutter (Phase 3)

Atrophy (Phase 4)

Bipolar Disorder (Phase 3)

Body Weight Changes (Phase 3)

Bone Diseases, Metabolic (Phase 4)

Brain Neoplasms (Phase 1)

Cardiovascular Diseases (Phase 3)

Chronic Pain (Phase 3)

Cognitive Dysfunction (Phase 3)

Compulsive Personality Disorder (Phase 4)

Coronary Artery Disease (Phase 3)

Coronary Disease (Phase 3)

Cystic Fibrosis (Phase 3)

Dementia (Phase 3)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Disease (Phase 2)

Dyslipidemias (Phase 3)

Endometriosis (Phase 2)

Eructation (Phase 3)

Exocrine Pancreatic Insufficiency (Phase 3)

Fibrosis (Phase 3)

Fissure in Ano (Phase 4)

Frailty (Phase 3)

Glioma (Phase 1)

Glucose Metabolism Disorders (Phase 3)

Headache (Phase 2)

Heart Failure (Phase 2)

Hemorrhoids (Phase 4)

Hip Fractures (Phase 3)

HIV Infections (Phase 2)

Hot Flashes (Phase 2)

Hyperlipidemias (Phase 3)

Hyperlipoproteinemias (Phase 3)

Hyperplasia (Phase 4)

Hypertension (Phase 3)

Hypertriglyceridemia (Phase 4)

Hypogonadism (Phase 4)

Influenza, Human (Phase 4)

Insulin Resistance (Phase 4)

Kidney Diseases (Phase 2)

Meniere Disease (Phase 4)

Mental Disorders (Phase 3)

Metabolic Diseases (Phase 3)

Metabolic Syndrome (Phase 4)

Migraine Disorders (Phase 2)

Migraine with Aura (Phase 2)

Migraine without Aura (Phase 2)

Myocardial Ischemia (Phase 3)

Nausea (Phase 3)

Neoplasm Metastasis (Phase 4)

Neuralgia (Phase 2)

Neuralgia, Postherpetic (Phase 2)

Obesity (Phase 2)

Obsessive-Compulsive Disorder (Phase 4)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Overweight (Phase 3)

Pancreatitis (Phase 4)

Pancreatitis, Chronic (Phase 4)

Parkinson Disease (Phase 4)

Problem Behavior (Phase 3)

Prostatic Hyperplasia (Phase 4)

Prostatic Neoplasms (Phase 2)

Psychotic Disorders (Phase 3)

Renal Insufficiency (Phase 2)

Schizophrenia (Phase 3)

Sleep Apnea Syndromes (Phase 2)

Syndrome (Phase 4)

Vomiting (Phase 3)

Weight Loss (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 145
# of Trial APIs: 77